tamoxifen Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (1)

Phase 1 (1)
Unknown (1)

Interventional (1)
Observational (1)

Jilin University (1)
SOLTI Breast Cancer Research Group (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadcancer

I am/have/hadbreast cancer

I am/have/hadmetastasis

I am/have/hadinvasive breast cancer

I am/have/hadadjuvant therapy

I am/have/hadplatelet count

I am/have/hadneutrophil count

I am/have/hadstage iv breast cancer

I am/have/hadadenocarcinoma of the breast

I am/have/hadadenocarcinoma

I am/have/hadglomerular filtration rate

I am/have/hadbone metastases

I am/have/hadher2-positive breast cancer

I am/have/hadaptt

I am/have/hadher2/neu-positive breast cancer

I am/have/hadformalin-fixed paraffin-embedded

I am/have/hadbilateral breast cancer

I am/have/hadserum bilirubin

I am/have/hadserum bilirubin level

I am/have/hadher2 positive breast carcinoma

added new label for I am/have/had

more

I am looking for

I am looking foradjuvant

I am looking fortrastuzumab

I am looking fortaxane

I am looking foripatasertib

I am looking forglycosylated hemoglobin

I am looking forimmunological adjuvant

I am looking forpertuzumab

I am looking forpik3ca

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients

This is an open label, single arm, multicenter, phase Ib study to evaluate the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic HER2-positive breast cancer with tumors harboring PIK3CA mutations, candidates to receive maintenance HP after first line …

glycosylated hemoglobin

bilateral breast cancer

breast cancer

pertuzumab

pik3ca

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 1000s
Observational Study
For Females
Recruiting

Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development

This study aims to prove whether antler disk extract can be put into clinical practice to prevent breast precancerous lesions from developing into cancer.

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.